Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy

Wingerchuk, 2007, The spectrum of neuromyelitis optica, Lancet Neurol, 6, 805, 10.1016/S1474-4422(07)70216-8

Wingerchuk, 2015, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology, 85, 177, 10.1212/WNL.0000000000001729

Kitley, 2013, Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies, JAMA Neurol, 70, 1375, 10.1001/jamaneurol.2013.3890

Yonezu, 2014, “Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis, Mult Scler Houndmills Basingstoke Engl, 20, 331, 10.1177/1352458513495581

Pekcevik, 2016, Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging, Mult Scler Houndmills Basingstoke Engl, 22, 302, 10.1177/1352458515591069

Zalewski, 2017, Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders, J Neurol Neurosurg Psychiatry, 88, 218, 10.1136/jnnp-2016-314738

Hyun, 2015, Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder?, J Neurol Neurosurg Psychiatry, 86, 1280, 10.1136/jnnp-2014-309761

Kister, 2016, findings help distinguish acute transverse myelitis of neuromyelitis optica from spinal cord infarction, Mult Scler Relat Disord, 9, 62, 10.1016/j.msard.2016.04.005

Neuromyelitis Optica Study Group (NEMOS), 2014, Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS), J Neurol, 261, 1, 10.1007/s00415-013-7169-7

Alves Do Rego, 2018, Neuromyelitis optica spectrum disorders: features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes, Rev Neurol (Paris), 174, 458, 10.1016/j.neurol.2018.02.084

Lee, 2009, Reversible aggravation of neurological deficits after steroid medication in patients with venous congestive myelopathy caused by spinal arteriovenous malformation, Interv Neuroradiol, 15, 325, 10.1177/159101990901500310

Thompson, 2018, Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria, Lancet Neurol, 17, 162, 10.1016/S1474-4422(17)30470-2

Vitali, 2002, Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group, Ann Rheum Dis, 61, 554, 10.1136/ard.61.6.554

Krupp, 2013, International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions, Mult Scler J, 19, 1261, 10.1177/1352458513484547

Transverse Myelitis Consortium Working Group, 2002, Proposed diagnostic criteria and nosology of acute transverse myelitis, Neurology, 59, 499, 10.1212/WNL.59.4.499

Stern, 2018, Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group, JAMA Neurol, 75, 1546, 10.1001/jamaneurol.2018.2295

Davatchi, 2014, The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria, J Eur Acad Dermatol Venereol, 28, 338, 10.1111/jdv.12107

1999, The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, Arthritis Rheum, 42, 599, 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F

Marignier, 2013, Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity, Neurology, 80, 2194, 10.1212/WNL.0b013e318296e917

Cobo-Calvo, 2017, MOG antibody-related disorders: common features and uncommon presentations, J Neurol, 264, 1945, 10.1007/s00415-017-8583-z

Pittock, 2006, Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression, Arch Neurol, 63, 964, 10.1001/archneur.63.7.964

Ameli, 2019, Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease, J Neuroradiol J Neuroradiol

Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310

Sato, 2014, Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: diagnostic considerations, Mult Scler Houndmills Basingstoke Engl, 20, 621, 10.1177/1352458513505350

Fujihara, 2012, Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease, Clin Exp Neuroimmunol, 3, 58, 10.1111/j.1759-1961.2012.00030.x

Misu, 2007, Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis, Brain, 130, 1224, 10.1093/brain/awm047

Cobo-Calvo, 2018, Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study, Neurology, 90, e1858, 10.1212/WNL.0000000000005560

Denève, 2019, MRI features of demyelinating disease associated with anti-MOG antibodies in adults, J Neuroradiol J Neuroradiol, 46, 312, 10.1016/j.neurad.2019.06.001

Chee, 2018, MRI features of aquaporin-4 antibody-positive longitudinally extensive transverse myelitis: insights into the diagnosis of neuromyelitis optica spectrum disorders, AJNR Am J Neuroradiol, 39, 782, 10.3174/ajnr.A5551

Cobo-Calvo, 2014, Etiologic spectrum and prognosis of longitudinally extensive transverse myelopathies, Eur Neurol, 72, 86, 10.1159/000358512